With more people at risk for cardiovascular disease than ever before, the Quest Cardiometabolic Center of Excellence™ at Cleveland HeartLab® is advancing a prevention-focused approach for heart disease and associated metabolic conditions.
- Cardiovascular disease is the leading cause of death for individuals who have T2DM,6 stage 4-5 CKD,2 and NAFLD.3
- Those who have T2DM have a 2 to 3 times higher risk of fatal coronary heart disease.7
- Nearly 40% of persons who have diabetes and more than 30% of those who have hypertension also have CKD.8 The leading causes of end-stage renal disease are diabetes and hypertension.9
- More than 75% of those who have T2DM have NAFLD.10